N-(1-{1-[4-Guanidino-1-(4-nitro-phenylcarbamoyl)-butylcarbamoyl]-2-methyl-propylcarbamoyl}-2-phenyl-ethyl)-benzamide

ID: ALA3144127

PubChem CID: 16219051

Max Phase: Preclinical

Molecular Formula: C33H40N8O6

Molecular Weight: 644.73

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)Nc1ccc([N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C33H40N8O6/c1-21(2)28(40-31(44)27(20-22-10-5-3-6-11-22)39-29(42)23-12-7-4-8-13-23)32(45)38-26(14-9-19-36-33(34)35)30(43)37-24-15-17-25(18-16-24)41(46)47/h3-8,10-13,15-18,21,26-28H,9,14,19-20H2,1-2H3,(H,37,43)(H,38,45)(H,39,42)(H,40,44)(H4,34,35,36)/t26-,27-,28-/m0/s1

Standard InChI Key:  QQVNCBCBFNWLJX-KCHLEUMXSA-N

Molfile:  

     RDKit          2D

 47 49  0  0  0  0  0  0  0  0999 V2000
    1.4698  -11.8894    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.6219   -8.9148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0091   -8.5716    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.8017   -8.8004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7833   -7.8851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6404   -9.8300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4146   -9.1436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1888   -8.4571    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0275   -9.4868    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.3962   -8.2283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8293   -5.7114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8477   -9.6012    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0643  -11.3173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2348   -9.2580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6772  -11.6605    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6680  -12.6902    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4238   -5.1393    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4238   -8.1139    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.9998   -9.6012    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.5759   -8.1139    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8385  -10.6309    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1980   -7.4275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5851   -7.0843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0275   -6.5122    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8569  -11.5461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8661  -10.5165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2532  -10.1732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0367   -5.4826    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.6127   -9.9444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4514  -10.9741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4606   -9.9444    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4054   -7.1987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0367   -8.4571    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1796   -6.5122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7925   -6.8554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4330   -7.0843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0183  -10.5165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4054  -10.1732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2072   -6.3978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8109   -7.7707    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6311   -7.8851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5943   -6.0546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9814   -5.7114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0183   -7.5419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4146   -6.1690    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1888   -5.4826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8201   -6.7410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  9  1  0
  3  7  1  0
  4  3  1  0
  5  8  1  0
  6 12  1  0
  7  2  1  0
  8 10  1  0
  9 14  1  0
 10  4  1  0
 11 24  2  0
 12 27  1  0
 13  1  1  0
 14  6  1  0
 15  1  1  0
 16  1  2  0
 17 11  1  0
 18  2  2  0
 19  4  2  0
 20  5  2  0
 21  6  2  0
 10 22  1  6
 23  5  1  0
 24 36  1  0
 25 13  2  0
 26 13  1  0
 27 31  1  0
 28 11  1  0
  7 29  1  1
 30 25  1  0
 31 26  2  0
 32 22  1  0
 14 33  1  6
 34 23  1  0
 35 23  2  0
 36 41  1  0
 37 29  1  0
 38 29  1  0
 39 32  2  0
 40 32  1  0
 41 33  1  0
 42 35  1  0
 43 34  2  0
 44 40  2  0
 45 39  1  0
 46 42  2  0
 47 44  1  0
 27 30  2  0
 45 47  2  0
 43 46  1  0
M  CHG  2   1   1  15  -1
M  END

Alternative Forms

Associated Targets(non-human)

PRSS1 Trypsin I (1205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 644.73Molecular Weight (Monoisotopic): 644.3071AlogP: 2.25#Rotatable Bonds: 16
Polar Surface Area: 223.94Molecular Species: BASEHBA: 7HBD: 6
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 8#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.69CX Basic pKa: 10.78CX LogP: 2.70CX LogD: 0.60
Aromatic Rings: 3Heavy Atoms: 47QED Weighted: 0.04Np Likeness Score: -0.37

References

1. Lu T, Tomczuk B, Illig CR, Bone R, Murphy L, Spurlino J, Salemme FR, Soll RM..  (1998)  In vitro evaluation and crystallographic analysis of a new class of selective, non-amide-based thrombin inhibitors.,  (13): [PMID:9873397] [10.1016/s0960-894x(98)00290-x]

Source